Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robson

Showing results (221-230 of 352) with videos related to

Pageof 36
Sort By:
Journal of the National Cancer Institute|September 22, 2005
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer familiesNoah D Kauff, Nandita Mitra, Mark E Robson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
European Journal of Radiology|November 21, 2017
Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot studyMaxine S Jochelson, Katja Pinker, D David Dershaw, et al.
Breast Cancer Research and Treatment|May 7, 2013
Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysisCarmen A Perez, Zachary S Zumsteg, Gaorav Gupta, et al.
Cancer|June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-upNoah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2018
A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patientsTing Bao, Andrew D Seidman, Lauren Piulson, et al.
Cancer|May 21, 2011
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancerZsofia K Stadler, Erin Salo-Mullen, Sujata M Patil, et al.
Neuroimage. Clinical|November 23, 2016
Abnormal visuomotor processing in schizophreniaSiân E Robson, Matthew J Brookes, Emma L Hall, et al.
Pageof 36

Showing results (221-230 of 352) with videos related to

Sort By:
Pageof 36
Journal of the National Cancer Institute|September 22, 2005
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer familiesNoah D Kauff, Nandita Mitra, Mark E Robson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerM E Robson, N Tung, P Conte, et al.
European Journal of Radiology|November 21, 2017
Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot studyMaxine S Jochelson, Katja Pinker, D David Dershaw, et al.
Breast Cancer Research and Treatment|May 7, 2013
Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysisCarmen A Perez, Zachary S Zumsteg, Gaorav Gupta, et al.
Cancer|June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-upNoah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2018
A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patientsTing Bao, Andrew D Seidman, Lauren Piulson, et al.
Cancer|May 21, 2011
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancerZsofia K Stadler, Erin Salo-Mullen, Sujata M Patil, et al.
Neuroimage. Clinical|November 23, 2016
Abnormal visuomotor processing in schizophreniaSiân E Robson, Matthew J Brookes, Emma L Hall, et al.
Pageof 36